Ambien and Esgic-plus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ambien (zolpidem tartrate) and Esgic-plus (acetaminophen; butalbital; caffeine). Common drug interactions include depression among females and dependence among males.

The phase IV clinical study analyzes what interactions people have when they take Ambien and Esgic-plus. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Ambien?

Ambien has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 93,519 Ambien users. Check the latest studies of Ambien.

What is Esgic-plus?

Esgic-plus has active ingredients of acetaminophen; butalbital; caffeine. It is often used in migraine. eHealthMe is studying from 269 Esgic-plus users. Check the latest studies of Esgic-plus.



On Jul, 14, 2026

28 people who take Ambien and Esgic-plus together, and have interactions are studied.

Ambien and Esgic-plus drug interactions.

What are the common drug interactions of Ambien and Esgic-Plus, by gender? *:

female:

  1. Depression
  2. Oedema lower limb (fluid collection in tissue of lower leg)
  3. Palpitations (feelings or sensations that your heart is pounding or racing)
  4. Fatigue (feeling of tiredness)
  5. Skin burning sensation
  6. Anxiety disorder
  7. Bipolar disorder (mood disorder)
  8. Bipolar i disorder (mood disorder that is characterized by at least one manic or mixed episode)
  9. Blood sodium increased
  10. Contusion (a type of hematoma of tissue in which capillaries)

male:

  1. Dependence
  2. Dependent personality disorder
  3. Loss of consciousness
  4. Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
  5. Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
  6. Personality disorder

What are the common drug interactions of Ambien and Esgic-Plus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  3. Cardiac murmur (an heart sound in valve abnormality)
  4. Dyspnoea (difficult or laboured respiration)
  5. Palpitations (feelings or sensations that your heart is pounding or racing)
  6. Oedema lower limb (fluid collection in tissue of lower leg)
  7. Blood sodium increased
  8. Oedema (fluid collection in tissue)

40-49:

  1. Abdominal pain
  2. Abdominal pain upper
  3. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  4. Anxiety
  5. Dehydration (dryness resulting from the removal of water)
  6. Depression
  7. Dizziness
  8. Drug ineffective
  9. Dysgeusia (disorder of the sense of taste)
  10. Dyspnoea (difficult or laboured respiration)

50-59:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Fall
  3. Depression
  4. Drug ineffective
  5. Eating disorder
  6. Foot fracture
  7. Gun shot wound
  8. Head injury
  9. Hospitalisation
  10. Hypersensitivity

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 17.86%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 17.86%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 17.86%
  4. Sleep Disorder: 4 people, 14.29%
  5. Headache (pain in head): 4 people, 14.29%
  6. Depression: 3 people, 10.71%
  7. Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 7.14%
  8. Oral Herpes (viral infection of mouth): 2 people, 7.14%
  9. Hypersensitivity: 2 people, 7.14%
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ambien and Esgic-plus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ambien and Esgic-plus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ambien:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Esgic-plus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ambien and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Esgic-plus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on zolpidem tartrate and acetaminophen; butalbital; caffeine (the active ingredients of Ambien and Esgic-plus, respectively), and Ambien and Esgic-plus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: